Inspire Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Inspire Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.49M	Hold	130,000	–	–	1.03%	32
2026 Q1	$7.88M	Hold	130,000	–	–	1.22%	20
2025 Q4	$7.01M	Buy	130,000 +13,000	+11%	+$625K	1.15%	22
2025 Q3	$5.28M	Buy	117,000 +10,000	+9%	+$467K	0.96%	39
2025 Q2	$4.95M	Buy	107,000 +35,000	+49%	+$1.72M	1.02%	33
2025 Q1	$4.39M	Buy	72,000 +14,000	+24%	+$816K	1.04%	30
2024 Q4	$3.28M	Sell	58,000 -45,500	-44%	-$2.54M	0.84%	48
2024 Q3	$5.36M	Buy	103,500 +29,044	+39%	+$1.36M	1.48%	15
2024 Q2	$3.09M	Buy	74,456 +20,315	+38%	+$909K	1.02%	29
2024 Q1	$2.94M	Buy	54,141 +24,805	+85%	+$1.26M	1.64%	14
2023 Q4	$1.51M	Buy	+29,336	New	+$1.54M	1.55%	13

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Inspire Trust Company's BMY Position: Q2 2026 in Review

Inspire Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 130,000 shares worth $7.49M. The position accounts for 1.03% of the portfolio, ranked #32.

Inspire Trust Company first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.88M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Inspire Trust Company held 130,000 shares of Bristol-Myers Squibb worth $7.49M as of Q2 2026.
Inspire Trust Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 1.03% of Inspire Trust Company's portfolio in Q2 2026, its #32 holding.
Inspire Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Inspire Trust Company's Bristol-Myers Squibb position peaked at $7.88M in Q1 2026.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Inspire Trust Company's 13F filing for Q2 2026, filed 5 Aug 2026.